|
Adnexus Therapeutics
100 Beaver Street
Waltham, MA 02453
Phone: (781) 891-3745
Fax: (781) 891-3796
Email: info@adnexustx.com
|
Adnexus Therapeutics develops protein therapeutics targeted towards inflammation, autoimmunity, cancer, and infections disease. These are developed on their PROfusion platform.
- History:
Adnexus Therapeutics started out as Compound Therapeutics, changing their name in 2006. They were acquired by Bristol-Meyers Squibb in 2007 where they now act as a subsidiary.
Acquisitions
Phylos (2004) |
